Mysterious Adderall shortage puts ADHD patients at risk
“The letter said the DEA would ensure that “the manufacturing of controlled substances used to treat ADHD is driven by a legitimate need and not improperly driven purely by profit motive, pressure from marketing firms, or a desire to obtain more market share – all factors that led to an oversupply of opioids during the prescription opioid crisis.”<p>As much as I hate to say it, this is fairly responsible behavior by regulators, who are likely betting that people without a real need will simply churn when it gets tougher to find some.<p>That said, it is sad that those with a disease that makes it difficult to plan and execute have to do exactly that to get their treatment.